Skip to main content

Oral Leukoplakia

  • Chapter
  • First Online:
Premalignant Conditions of the Oral Cavity

Part of the book series: Head and Neck Cancer Clinics ((HNCC))

Abstract

Oral leukoplakia (New Latin leuko, white, + classical Greek plax, flat object) is said to represent the most common premalignant oral mucosal lesion with an estimated global prevalence rate of 2.6%. Historically, practitioners have used many synonyms such as leucoma, smokers’ patch, leukokeratosis and ichthyosis for this lesion. In 1851, Sir James Paget documented a connection between a white keratotic oral lesion and lingual carcinoma; however, the term “leukoplakia” has given rise to considerable misunderstanding since it was first defined more than 140 years ago by the dermatologist Ernst Schwimmer in 1877 [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770–80.

    Article  Google Scholar 

  2. Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med. 1995;6:147–60.

    Article  CAS  Google Scholar 

  3. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45:155–66.

    Article  CAS  Google Scholar 

  4. Axell T, Holmstrup P, Kramer IRH, Pindborg JJ, Shear M. International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol. 1984;12:145–54.

    Article  Google Scholar 

  5. Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I. Histological typing of cancer and precancer of the oral mucosa. World Health Organization International histological classification of tumours. Berlin: Springer; 1997.

    Book  Google Scholar 

  6. Chi AC, Lambert PR, Pan Y, Li R, Vo DT, Edwards E, et al. Is alveolar ridge keratosis a true leukoplakia? A clinicopathologic comparison of 2,153 lesions. J Am Dent Assoc. 2007;138:641–51.

    Article  Google Scholar 

  7. Natarajan E, Woo SB. Benign alveolar ridge keratosis (oral lichen simplex chronicus): a distinct clinicopathologic entity. J Am Acad Dermatol. 2008;58:151–7.

    Article  Google Scholar 

  8. van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20:e685–92.

    Article  Google Scholar 

  9. van der Waal I. Greenspan lesion is a better term than “hairy leukoplakia”. J Oral Pathol Med. 1996;25:144.

    Article  Google Scholar 

  10. Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppasala, Sweden, May 18-21, 1994. International collaborative group on oral white lesions. J Oral Pathol Med. 1996;25:49–54.

    Article  CAS  Google Scholar 

  11. Mehta FS, Hammer JE. Tobacco-related oral mucosal lesions and conditions in India, A guide for dental students, dentists, and physicians. Bombay: Basic Dental Research Unit, Tata Institute of Fundamental Research; 1993.

    Google Scholar 

  12. Warnakulasuriya S, Dietrich T, Bornstein MM, Casals PE, Preshaw PM, Walter C, et al. Oral health risks of tobacco use and effects of cessation. Int Dent J. 2010;60:7–30.

    PubMed  Google Scholar 

  13. Gupta PC, Mehta FS, Daftary DK. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dental and Oral Epidemiology. 1980;8:287–333.

    Article  Google Scholar 

  14. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317–23.

    Article  Google Scholar 

  15. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1–10.

    Article  Google Scholar 

  16. Khan Z, Khan S, Christianson L, Rehman S, Ekwunife O, Samkange-Zeeb F. Smokeless tobacco and oral potentially malignant disorders in South Asia: a systematic review and meta-analysis. Nicotine Tob Res. 2016;5:142.

    Google Scholar 

  17. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol. 2010;46:423–5.

    Article  Google Scholar 

  18. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin. 2000;50:7–33.

    Article  CAS  Google Scholar 

  19. Paricio-Rubio J, Revenga-Arranz J, Ramírez-Gasca T, Boned-Blas P. Leucoqueratosis nicotínica del paladar. Actas Dermosifiliogr. 2002;93:38–41.

    Article  Google Scholar 

  20. Jepsen A, Winther JE. Mycotic infection in oral leukoplakia. Acta Ondontol Scand. 1965;23:239–56.

    Article  CAS  Google Scholar 

  21. Renstrup G. Occurrence of candida in oral leukoplakias. Acta Pathol Microbiol Scand. 1970;78:421–4.

    CAS  Google Scholar 

  22. Palefsky JM, Silverman S, Abdel‐Salaam M, Daniels TE, Greenspan JS. Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med. 1995;24:193–7.

    Article  CAS  Google Scholar 

  23. Praetorius F. HPV-associated diseases of oral mucosa. Clin Dermatol. 1997;15:299–413.

    Article  Google Scholar 

  24. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a metaanalysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622–35.

    Article  CAS  Google Scholar 

  25. Bagán JV, Jiménez Y, Murillo J, Poveda R, Díaz JM, Gavaldá C, et al. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: a preliminary study. Med Oral Patol Oral Cir Bucal. 2008;13:E110–3.

    PubMed  Google Scholar 

  26. Salati NA, Khwaja KJ, Anwer M. Pathogenesis of potentially malignant disorders. Guident. 2012;5:60–2.

    Google Scholar 

  27. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol. 1997;33:291–301.

    Article  Google Scholar 

  28. Warnakulasuriya S, Johnson NW, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.

    Article  CAS  Google Scholar 

  29. Hansen LS, Olson JA, Silverman S. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol. 1985;60:285–98.

    Article  CAS  Google Scholar 

  30. Bagan JV, Jiménez-Soriano Y, Diaz-Fernandez JM, et al. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases. Oral Oncol. 2011;47:732–5.

    Article  Google Scholar 

  31. Cerero-Lapiedra R, Baladé-Martínez D, Moreno-López LA, Esparza-Gómez G, Bagán JV. Proliferative verrucous leukoplakia: a proposal for diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2010;15:e839–45.

    Article  Google Scholar 

  32. Carrard VC, Brouns EREA, van der Waal I. Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria. Med Oral Patol Oral Cir Bucal. 2013;18:e411–3.

    Article  Google Scholar 

  33. Cabay RJ, Morton TH, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med. 2007;36:255–61.

    Article  Google Scholar 

  34. Pindborg JJ, Reibel J, Roed-Petersen B, Mehta FS. Tobacco-induced changes in oral leukoplakic epithelium. Cancer. 1980;45:2330–6.

    Article  CAS  Google Scholar 

  35. Daniels TE, Hansen LS, Greenspan JS, et al. Histopathology of smokeless tobacco lesions in professional baseball players. Association with different types of tobacco. Oral Surg Oral Med Oral Pathol. 1992;73:720–5.

    Article  CAS  Google Scholar 

  36. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:321–9.

    Article  CAS  Google Scholar 

  37. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Endod. 1995;80:188–91.

    Article  CAS  Google Scholar 

  38. Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1972;33:389–99.

    Article  CAS  Google Scholar 

  39. Bánóczy J. Follow up studies in oral leukoplakia. J Maxillofac Surg. 1977;5:69–75.

    Article  Google Scholar 

  40. Cowan CG, Gregg TA, Napier SS, McKenna SM, Kee F. Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001;7:18–24.

    CAS  PubMed  Google Scholar 

  41. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42:987–93.

    Article  Google Scholar 

  42. Parlatescu I, Gheorghe C, Coculescu E, Tovaru S. Oral leukoplakia–an update. Maedica. 2014;9:88.

    PubMed  PubMed Central  Google Scholar 

  43. van der Waal I, Schepman KP, Van der Meij EH. A modified classification and staging system for oral leukoplakia. Oral Oncol. 2000;36:264–6.

    Article  Google Scholar 

  44. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14:47–62.

    Article  Google Scholar 

  45. Kramer IR, el-Labban N, Lee KW. The clinical features and risk of malignant transformation in sublingual keratosis. Nr Dent J. 1978;144:171–80.

    Article  CAS  Google Scholar 

  46. Duncan KO, Geisse JK, Leffel DJ. Epidermal and appendageal tumors. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York, NY: McGraw Hill; 2007. p. 1024–6.

    Google Scholar 

  47. Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int J Dent. 2012;2012:1–7.

    Article  Google Scholar 

  48. Nasser W, Flechtenmacher C, Holzinger D, et al. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. J Oral Pathol Med. 2011;40:629–35.

    Article  CAS  Google Scholar 

  49. Reddy SG, Reddy SG, Kanala S, et al. The sensitivity and specificity of computerized brush biopsy and scalpel biopsy in diagnosing oral premalignant lesions: a comparative study. J Oral Maxillofac Pathol. 2012;16:349–53.

    Article  Google Scholar 

  50. Lingen MW, Kalmar JR, Karrison T, et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22.

    Article  Google Scholar 

  51. Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med. 2011;40:541–4.

    Article  CAS  Google Scholar 

  52. Ganga RS, Gundre D, Bansal S, Shirsat PM, Prasad P, Desai RS. Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope. Oral oncology. 2017;75:67–74.

    Article  Google Scholar 

  53. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006;(4):CD001829.

    Google Scholar 

  54. Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl S19):e1–12.

    Google Scholar 

  55. Ho MW, Risk JM, Woolgar JA, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012;48:969–76.

    Article  CAS  Google Scholar 

  56. William WN. Oral premalignant lesions. Curr Opin Oncol. 2012;24:205–10.

    Article  CAS  Google Scholar 

  57. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008;37:63–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Peter A. Brennan, Tom Aldridge, Raghav C. Dwivedi, Rehan Kazi

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Desai, R.S., Ganga, R.S., Dwivedi, R.C. (2019). Oral Leukoplakia. In: Brennan, P., Aldridge, T., Dwivedi, R. (eds) Premalignant Conditions of the Oral Cavity. Head and Neck Cancer Clinics. Springer, Singapore. https://doi.org/10.1007/978-981-13-2931-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2931-9_4

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2930-2

  • Online ISBN: 978-981-13-2931-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics